RxDoctor Payments Data

Samuel Esposito, PA

Physician Assistant · Williamsport, PANPI 1245749894

Payments from drug & device makers

$4,884in general payments, 2019–2025

Across 287 payments — averaging $17.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Novo Nordisk$634
  • Lilly USA, LLC$583
  • GSK$415
  • AstraZeneca$317
  • Pfizer$280
  • plus $2K from 20 others

What the payments were for

  • Food & beverage$4,884100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,884 in reported general payments places this provider in the 90th percentile of 6,643 physician assistant providers in Pennsylvania.

See all physician assistant providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$15,821
Medicare patients
109
Services billed
337

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban113$84,440
OzempicSemaglutide45$61,015
TrulicityDulaglutide33$44,691
MounjaroTirzepatide43$44,307
JardianceEmpagliflozin23$24,659
Breztri AerosphereBudesonide/Glycopyr/Formoterol31$22,905
RybelsusSemaglutide17$18,480
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr24$15,708
Trelegy ElliptaFluticasone/Umeclidin/Vilanter24$15,169
XareltoRivaroxaban16$11,313
Breo ElliptaFluticasone/Vilanterol19$11,160
ZoloftSertraline Hcl12$7,321
Repatha SyringeEvolocumab12$6,626
Spiriva HandihalerTiotropium Bromide11$6,295
Arnuity ElliptaFluticasone Furoate21$4,558

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$583$88,99976 claims
PfizerEliquis$280$84,440113 claims
Novo NordiskOzempic, Rybelsus$634$79,49562 claims
GSKAnoro Ellipta, Trelegy Ellipta, Breo Ellipta, Arnuity Ellipta$415$46,59488 claims
Boehringer IngelheimJardiance$109$24,65923 claims
AstraZenecaBreztri Aerosphere$317$22,90531 claims
Johnson & JohnsonXarelto$36$11,31316 claims
AbbVieSynthroid$1,124$80728 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 6,643 physician assistant providers in Pennsylvania.

Other physician assistant in Williamsport

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →